Assignee
STEALTH BIOTHERAPEUTICS CORP
MC·32 granted patents·44 pending applications·131 citations·filing 2013–2021
Top patents by PatentIndex Score
76 records- 0197US11034724B2Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2STEALTH BIOTHERAPEUTICS CORP·Filed 2018·Granted Jun 15, 2021·5 cites·14 claims
- 0296US11083772B2Methods and compositions for the prevention or treatment of Barth SyndromeSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Granted Aug 10, 2021·5 cites·15 claims
- 0396US9549963B2Methods and compositions for preventing or treating ophthalmic conditionsSTEALTH BIOTHERAPEUTICS CORP·Filed 2015·Granted Jan 24, 2017·17 cites·9 claims
- 0495US10188692B2Methods and compositions for preventing or treating ophthalmic conditionsSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Jan 29, 2019·8 cites·9 claims
- 0594US10835573B2Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levelsSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Nov 17, 2020·4 cites·9 claims
- 0694US10047395B2Methods and compositions for detecting and diagnosing diseases and conditionsSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Aug 14, 2018·10 cites·8 claims
- 0793US10683326B2Crystalline salt formsSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Jun 16, 2020·6 cites·15 claims
- 0893US10676506B2Crystalline bis- and tris-hydrochloride salt of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Jun 9, 2020·6 cites·19 claims
- 0993US10576124B2Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereofSTEALTH BIOTHERAPEUTICS CORP·Filed 2015·Granted Mar 3, 2020·6 cites·6 claims
- 1092US10744178B2Methods and compositions for the prevention and treatment of diseaseSTEALTH BIOTHERAPEUTICS CORP·Filed 2015·Granted Aug 18, 2020·4 cites·9 claims
- 1191US10975118B2Crystalline dipeptides useful in the synthesis of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Apr 13, 2021·4 cites·4 claims
- 1291US10293020B2Peptide therapeutics and methods for using sameSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted May 21, 2019·7 cites·5 claims
- 1391US10188693B2Methods for treatment of atherosclerosisSTEALTH BIOTHERAPEUTICS CORP·Filed 2013·Granted Jan 29, 2019·6 cites·6 claims
- 1489US11083771B2Methods and compositions for the prevention or treatment of Barth SyndromeSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Aug 10, 2021·5 cites·18 claims
- 1589US9687519B2Methods and compositions for the prevention or treatment of barth syndromeSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Jun 27, 2017·8 cites·6 claims
- 1688US10961273B2N-carboxyanhydride-based-scale synthesis of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Mar 30, 2021·4 cites·20 claims
- 1788US10702577B2Combination therapies using cyclosporine and aromatic cationic peptidesSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Jul 7, 2020·2 cites·14 claims
- 1887US10793597B2Methods for the treatment of mitochondrial diseases associated with a mutation in SURF 1 or POLG gene resulting in a disruption of mitochondrial oxidative phosphorylationSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Oct 6, 2020·7 cites·6 claims
- 1987US10221213B2Pharmaceutically relevant aromatic-cationic peptidesSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Mar 5, 2019·5 cites·17 claims
- 2085US10627392B2Methods of identifying and monitoring mitochondrial dysfunction using monocyte screeningSTEALTH BIOTHERAPEUTICS CORP·Filed 2015·Granted Apr 21, 2020·2 cites·20 claims
- 2184US11141456B2Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereofSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Granted Oct 12, 2021·1 cites·12 claims
- 2283US9877997B2Methods and compositions for regulating SRCA2A expression levels in myocardial infarctionSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Jan 30, 2018·2 cites·10 claims
- 2380US11325943B2Crystalline salt forms of SBT-20STEALTH BIOTHERAPEUTICS CORP·Filed 2018·Granted May 10, 2022·1 cites·14 claims
- 2480US10646539B2Methods and compositions for the treatment of neuropathy and hyperalgesiaSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted May 12, 2020·1 cites·20 claims
- 2578US10279008B2Methods and compositions for increasing the dose of a chemotherapeutic agentSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted May 7, 2019·1 cites·9 claims
- 2676US9884085B2Methods for the regulation of matrix metalloproteinase expressionSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Feb 6, 2018·2 cites·18 claims
- 2776US2020407396A1Methods for the treatment of mitochondrial diseaseSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 2876US2020360462A1Methods for reducing risks associated with heart failure and factors associated therewithSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 2975US11266709B2Methods for the regulation of matrix metalloproteinase expressionSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Mar 8, 2022·0 cites·12 claims
- 3075US10525098B2Methods for the regulation of matrix metalloproteinase expressionSTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Granted Jan 7, 2020·1 cites·18 claims
- 3174US2020061147A1Methods and compositions for preventing or treating ophthalmic conditionsSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 3274US2021130402A1Aromatic-cationic peptides and uses of sameSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 3372US2021401925A1Methods and compositions for preventing or treating dominant optic atrophySTEALTH BIOTHERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 3472US2016193278A1Methods and compositions for preventing or treating leber's hereditary optic neuropathySTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Application pending·0 cites
- 3571US2019365846A1Methods and compositions for preventing or treating leber's hereditary optic neuropathySTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 3671US2020000870A1Methods for treatment of atherosclerosisSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 3770US2019358286A1Methods for the prevention or treatment of left ventricle remodelingSTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 3870US2020397850A1Methods and compositions for the prevention and treatment neuropathySTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 3969US2018207225A1Methods and compositions for the prevention and treatment of friedreich's ataxiaSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 4068US10322159B2Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injurySTEALTH BIOTHERAPEUTICS CORP·Filed 2016·Granted Jun 18, 2019·1 cites·11 claims
- 4168US2020113966A1Methods and compositions for regulating srca2a expression levels in myocardial infarctionSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 4268US2018339012A1Methods for treatment of atherosclerosisSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 4368US2021046146A1Methods for performing a coronary artery bypass graft procedureSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4468US2021038677A1Methods and compositions for preventing or treating leber's hereditary optic neuropathySTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4568US2021023160A1Methods for the prevention or treatment of vessel occlusion injurySTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4667US2018344797A1Methods for treatment of atherosclerosisSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 4767US2016256514A1Methods for the prevention or treatment of left ventricle remodelingSTEALTH BIOTHERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 4865US2019106458A1Aromatic-cationic peptides and uses of sameSTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 4964US2019374596A1Peptide therapeutics and methods for using sameSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 5063US2019365845A1Methods for performing a coronary artery bypass graft procedureSTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when STEALTH BIOTHERAPEUTICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →